Show simple item record

dc.contributor.authorKamal, Sabiha
dc.date.accessioned2017-08-12T13:08:03Z
dc.date.available2017-08-12T13:08:03Z
dc.date.issued2017-08-12
dc.identifier.urihttp://hdl.handle.net/20.500.11948/1870
dc.description.abstractLinagliptin is a dipeptidyl peptidase 4 (DPP-4) inhibitors developed by Boehringer Ingelheim,which can be used to treat diabetes mellitus type-II. This study is done to compare the parameters (weight variation, hardness, disintegration, dissolution and assay) of film coated Linagliptin tablets. Different brands of Linagliptin tablets were collected from retail pharmacy of Bangladesh market for their evaluation test and compare with innovator drug (Trajenta). As it is an INN (International Nonproprietary Names) drug, specified method from ICH Guideline is followed for their evaluation test. The results of weight variation (±2), hardness (3.8-5.3kg/cm2), disintegration time (1.47 to 3.85 minutes), dissolution (97-106% in 0.1N HCl within 45 minutes) and assay (95-105%) tests of all marketed products comply with the Innovator drug and also with the specification. This study is done to view the scenario of the quality of different brands of Linagliptin tablets in Bangladesh market and to compare with innovator drug.en_US
dc.language.isoen_USen_US
dc.publisherDaffodil International Universityen_US
dc.relation.ispartofseries;P05051
dc.titleComparative Study of Different Brands of Linagliptin Tablet with Innovator drugen_US
dc.typeThesisen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record